Photo via BBC News

'I can get more time': Breast cancer patient finds out she can get life extending drug

Read the original at BBC News ↗
Cite

'I can get more time': Breast cancer patient finds out she can get life extending drug. (2026, September 17). BBC News. https://www.bbc.co.uk/news/videos/c6wyz8qg0g58o?at_medium=RSS&at_campaign=rss

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

BBC News · collected 2026-09-17

Quick Summary

A breast cancer patient in England with HER2-low metastatic breast cancer has expressed overwhelming relief after learning that the life-extending drug Enhertu is now available on the NHS, providing patients an average of nearly seven more months to live. The drug has been accessible in Scotland and 26 other European countries since at least 2023, while Wales is expected to soon approve its use, though Northern Ireland does not yet have automatic access. Kate Wills, a 51-year-old patient whose cancer has spread to her bones and lungs, reacted emotionally to the news, emphasizing the significant hope it brings in managing her condition.
Written by AI on 2026-09-17, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

Enhertu, a life-extending drug for patients with HER2-low breast cancer, is now available on the NHS in England starting from Thursday. About 1,000 women per year will benefit from this decision, which follows two years of negotiations over its cost and nearly two decades of campaigning by charities and patients. The drug extends patient life expectancy by an average of almost seven months, with some living up to three years longer than without it. Women in Scotland have had access since 2023, and it is available in 26 other European countries. Health Secretary Yvette Cooper praised the decision as a testament to persistent campaigning efforts and improvements in the NHS framework for accessing cutting-edge treatments.

Written for “Breast Cancer Drug Access England” on 2026-11-21, grounded in this article and the 2 other(s) covering the same event.

How they differ

2 outlets covered “Breast Cancer Drug Access England”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

BBCThis outlet17 Sep

A breast cancer patient in England with HER2-low metastatic breast cancer has expressed overwhelming relief after learning that the life-extending drug Enhertu is now available on the NHS, providing patients an average of nearly seven more months to live. The drug has been accessible in Scotland and 26 other European countries since at least 2023, while Wales is expected to soon approve its use, though Northern…

'I can get more time': Breast cancer patient finds out she can get life extending drug (this article)2 articles from BBC on this story
The Guardian17 Sep

Ministers and drug makers AstraZeneca and Daiichi Sankyo reached an agreement on pricing for Enhertu, allowing approximately 1,000 women in England with HER2-low advanced breast cancer to receive the life-extending drug starting Thursday. The National Institute for Health and Care Excellence (Nice) previously rejected the drug due to its cost but now recommends routine NHS use after negotiations led to a new pricing…

Women in England with incurable breast cancer to get life-extending drug on NHS →

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.
BBC News
Hedges 5 of 44 claims Outlet record 65/100
The Guardian
Hedges 1 of 23 claims Outlet record 64/100
“Article A describes the policy change and negotiations for making Enhertu available on NHS in England, while Article B focuses on a patient's reaction to being able to access the drug, which is more about individual impact than the specific event of policy implementation.”

Story

Breast Cancer Drug Access England
Health · 3 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
11
sentences that state something as happening or true
Uncertain
0%
0 of 11 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
65/100
BBC News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
3
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-17 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

BBC News · 6387 article(s) · 9 correction(s) detected
Running correction rate · 9 correction(s)

Who wrote this

No reporter is named on this article.

Topics

England Enhertu European NHS Scotland

Subjects

NHS ORG · 3× England GPE · 2× European NORP · 1× Kate Wills PERSON · 1× Northern Ireland GPE · 1× Scotland GPE · 1× Wales GPE · 1×

Narrative

Breast cancer patient finds out she can get life extending drug Patients in England with a specific type of incurable breast cancer can now access a life-extending drug on the NHS.
framing: assertive · carried by 1 article(s) · first seen 2026-09-17
Doctors in England are now able to prescribe it, with Wales expected to follow shortly but the guidance doesn't automatically apply to Northern Ireland.

Claims (11 extracted, 0 hedged)

'I can get more time - that's everything': asserted
that → get → time
Breast cancer patient finds out she can get life extending drug Patients in England with a specific type of incurable breast cancer can now access a life-extending drug on the NHS. asserted
Patients → find → NHS
Enhertu can give patients almost seven extra months to live on average. asserted
Enhertu → give → months
Women in Scotland have had access to the drug on the NHS since 2023, and it is available in 26 other European countries. asserted
it → have → countries
Doctors in England are now able to prescribe it, with Wales expected to follow shortly but the guidance doesn't automatically apply to Northern Ireland. asserted
guidance → prescribe → Ireland
Kate Wills, 51, has HER2-low metastatic breast cancer, which has spread to her bones and lungs. asserted
which → have → bones
When she hears it will be available on the NHS, she immediately starts crying. asserted
she → hear → NHS
"I really can't believe it. asserted
I → believe → it
I'm so relieved, I'm overjoyed," she says. asserted
she → overjoy → ?
"It's so hard keeping hope when you have stage four cancer. asserted
you → keep → cancer
This gives me enormous hope." asserted
This → give → hope
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support